Piper Sandler Maintains EDAP TMS(EDAP.US) With Buy Rating, Cuts Target Price to $5
H.C. Wainwright Maintains EDAP TMS(EDAP.US) With Buy Rating, Maintains Target Price $19
Edap TMS Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Edap TMS, Maintains $19 Price Target
H.C. Wainwright Maintains EDAP TMS(EDAP.US) With Buy Rating, Maintains Target Price $19
EDAP TMS: Strategic Growth and Diverse Revenue Streams Support Buy Rating
Lake Street Maintains EDAP TMS(EDAP.US) With Buy Rating, Maintains Target Price $10
Lake Street Keeps Their Buy Rating on EDAP TMS (EDAP)
Piper Sandler Maintains EDAP TMS(EDAP.US) With Buy Rating, Maintains Target Price $9
Analysts' Opinions Are Mixed on These Healthcare Stocks: Apellis Pharmaceuticals (APLS) and EDAP TMS (EDAP)
Edap TMS Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Edap TMS, Maintains $19 Price Target
H.C. Wainwright Maintains EDAP TMS(EDAP.US) With Buy Rating, Maintains Target Price $19
Buy Rating on EDAP TMS Maintained Despite Mixed Phase 3 Results, Highlighting Potential of HIFU for Endometriosis
Edap TMS Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN), Longeveron (LGVN) and EDAP TMS (EDAP)
Lake Street Reaffirms Their Buy Rating on EDAP TMS (EDAP)
HC Wainwright & Co. Maintains Buy on Edap TMS, Raises Price Target to $19
Edap TMS Analyst Ratings
EDAP TMS (EDAP) Receives a Buy From Piper Sandler